(1)
Turnšek, N.; Devjak, R.; Edelbaher, N.; Osrajnik, I.; Unk, M.; Vidovič, D.; Jerič, T.; Janžič, U. Real-World Outcomes, Treatment Patterns and T790M Testing Rates in Non-Small Cell Lung Cancer Patients Treated With First-Line First- or Second-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors from the Slovenian Cohort of the REFLECT: Outcomes and Treatments of EGFR-Mutated NSCLC Patients from Slovenia. RO 2022, 56, 371-379.